Syncephalastrum massiliense sp. nov. and Syncephalastrum timoneanum sp. nov. Isolated from Clinical Samples
Open Access
- 13 January 2024
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (1) , 64
Abstract
Mucormycosis is known to be a rare opportunistic infection caused by fungal organisms belonging to the Mucorales order, which includes the Syncephalastrum species. These moulds are rarely involved in clinical diseases and are generally seen as contaminants in clinical laboratories. However, in recent years, case reports of human infections due to Syncephalastrum have increased, especially in immunocompromised hosts. In this study, we described two new Syncephalastrum species, which were isolated from human nails and sputum samples from two different patients. We used several methods for genomic and phenotypic characterisation. The phenotypic analysis relied on the morphological features, analysed both by optical and scanning electron microscopy. We used matrix-assisted laser desorption–ionization time-of-flight mass spectrometry, energy-dispersive X-ray spectroscopy, and BiologTM technology to characterise the proteomic, chemical mapping, and carbon source assimilation profiles, respectively. The genomic analysis relied on a multilocus DNA sequence analysis of the rRNA internal transcribed spacers and D1/D2 large subunit domains, fragments of the translation elongation factor-1 alpha, and the β-tubulin genes. The two novel species in the genus Syncephalastrum, namely S. massiliense PMMF0073 and S. timoneanum PMMF0107, presented a similar morphology: irregular branched and aseptate hyphae with ribbon-like aspects and terminal vesicles at the apices all surrounded by cylindrical merosporangia. However, each species displayed distinct phenotypic and genotypic features. For example, S. timoneanum PMMF0107 was able to assimilate more carbon sources than S. massiliense PMMF0073, such as adonitol, α-methyl-D-glucoside, trehalose, turanose, succinic acid mono-methyl ester, and alaninamide. The polyphasic approach, combining the results of complementary phenotypic and genomic assays, was instrumental for describing and characterising these two new Syncephalastrum species.Keywords
All Related Versions
Funding Information
- Institut Hospitalo-Universitaire (IHU) Méditerranée Infection (Méditerranée Infection 10-IAHU-03)
- Agence Nationale de la Recherche (Méditerranée Infection 10-IAHU-03)
- Région Provence-Alpes-Côte d’Azur, European ERDF funding (Méditerranée Infection 10-IAHU-03)
- PRIMMI (Plateformes de Recherche et d’Innovation Mutualisées Méditerranée Infection) (Méditerranée Infection 10-IAHU-03)
This publication has 42 references indexed in Scilit:
- The family structure of the Mucorales: a synoptic revision based on comprehensive multigene-genealogiesPersoonia - Molecular Phylogeny and Evolution of Fungi, 2013
- MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice Across a Large Model SpaceSystematic Biology, 2012
- Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order MucoralesJournal of Clinical Microbiology, 2012
- Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia SpeciesClinical Microbiology Reviews, 2011
- Subcutaneous zygomycosis: report of 10 cases from two institutions in North IndiaJournal of the European Academy of Dermatology and Venereology, 2010
- Syncephalastrum species producing mycetoma-like lesionsIndian Journal of Dermatology, Venereology and Leprology, 2010
- Sino-orbital infection by syncephalastrum racemosum in chronic hepatorenal diseaseJournal of Oral and Maxillofacial Pathology, 2008
- In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2007
- Implications of Detecting the Mold Syncephalastrum in Clinical Specimens of New Orleans Residents After Hurricanes Katrina and RitaJournal of Occupational and Environmental Medicine, 2007
- In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the EtestAntimicrobial Agents and Chemotherapy, 2007